REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.80
Bid: 57.40
Ask: 58.00
Change: 0.50 (0.87%)
Spread: 0.60 (1.045%)
Open: 57.00
High: 57.80
Low: 57.00
Prev. Close: 57.20
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Feb 2011 16:37

RNS Number : 7439A
Accsys Technologies PLC
04 February 2011
 



Regulatory Announcement

Company

Accsys Technologies PLC

 

 

TIDM

AXS

Headline

Directors and Persons Discharging Managerial Responsibilities' Interests

Released

4th February 2011

Number

 

 

AIM: AXS

NYSE Euronext Amsterdam: AXS

4th February 2011

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Directors and Persons Discharging Managerial Responsibilities' Interests

 

Further to the Company's announcement of earlier today relating to its proposed €30 million fundraising by way of firm placing and placing and open offer (the "Firm Placing and Placing and Open Offer"), in compliance with the AIM Rules and Disclosure and Transparency Rules, the Company announces that the following directors and persons discharging managerial responsibilities have agreed to subscribe, pursuant to the terms of the Firm Placing and Placing and Open Offer, for the following number of ordinary shares of €0.01 in the Company ("Ordinary Shares") at a price of €0.15 per Ordinary Share, being the offer price under the Firm Placing and Placing and Open Offer (the "Subscriptions"):

 

Name

Number of Ordinary Shares

Gordon Campbell

73,333

Paul Clegg

300,000

Hans Pauli

200,000

Patrick Shanley

166,666

Lord Sanderson of Bowden

14,666

Michiel Maes

7,694

Edward Pratt

300,000

 

Further details relating to the Subscriptions are set out in the prospectus relating to the Firm Placing and Open Offer expected to be published by the Company today (the "Prospectus").

 

In connection with the Firm Placing and Placing and Open Offer, the Board has also approved the adjustment of share option awards granted prior to today's date pursuant to, and as provided for, in each of the Company's 2005 Unapproved Share Option Scheme and 2008 Unapproved Share Option Scheme (each a "Scheme"). Such ordinary course anti-dilution adjustments have been recommended by the nomination and remuneration committee of the Company and, as required under each Scheme, the auditors of the Company have opined that such adjustments have been calculated in a fair and reasonable manner. In respect of all options granted under each Scheme (including to Paul Clegg and Hans Pauli as executive directors), the exercise price shall be adjusted to 70.6% of the previous exercise price and the number of shares under option shall be increased by 141.7%.

 

The Company further announces that in connection with employee remuneration and incentivisation arrangements and in respect of the period from 31 March 2010 to 31 December 2010, the nomination and remuneration committee of the Company has resolved to issue Ordinary Shares to an Employee Benefit Trust, the beneficiaries of which are set out below. Such Ordinary Shares shall vest if the employees remain in employment with the Company to the vesting date, being 31 December 2011 (subject to certain other provisions including good-leaver, take-over and committee discretion provisions):

 

Name

Number of Ordinary Shares

Paul Clegg

750,000

Hans Pauli

500,000

Edward Pratt

250,000

Michiel Maes

250,000

Hal Stebbins

250,000

William Rudge

250,000

Angus Dodwell

250,000

 

Ends

 

 

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

via Citigate Dewe Rogerson

Matrix Corporate Capital LLP

 

 

Stephen Mischler

Nick Stone

Edmund Glover

+44 20 3206 7000

 

 

Numis Securities Limited

Christopher Wilkinson

Simon Blank

+44 20 7260 1347

+44 20 7260 1409

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

Notes to editors:

Accsys Technologies PLC (www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands, a European office in London and an Americas office in Dallas, Texas. Accsys Technologies' operations comprise three principal business units: (i) the Accoya® wood production facility located in Arnhem, The Netherlands; (ii) technology development, focused on a programme of continuous improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood fibre; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.info) is produced by using a proprietary, non-toxic process that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood" via acetylation. Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most woods, its colour does not degrade when exposed to sunlight. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, increased coatings life, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. Leading applications include external doors and windows, shutters/shading, siding and cladding, decking, outdoor furniture/equipment and glulam beams for structural use. 

Tricoya® Wood Elements (www.tricoya.com) is Accsys Technologies' proprietary technology for the acetylation of wood fibres, chips, and particles for use in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications which were once limited to solid wood or man-made products. Tricoya® Wood Elements is lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process, which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The environmentally responsible process protects wood from rot by making it "inedible" to most micro-organisms and insects, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance. Acetylated wood's increased durability offers major carbon sequestration advantages, compared to other woods and man-made building materials such as steel, vinyl, and plastic.

Wood Composites include a range of derivative wood products which are manufactured by binding together the strands, particles, fibres, or veneers of wood together with adhesives to form composite materials. These products are engineered to precise design specifications which are tested to meet national or international standards.

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited and may not be used or reproduced without written permission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQZLFBFLFXBBQ
Date   Source Headline
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.